NEUROD1 Protein

NEUROD1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NEUROD1 Protein</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-NEUROD1 for neuronal conversion</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>NEUROD1 activators</td>
</tr>
<tr>
<td class="label">Cell therapy</td>
<td>Stem cells + NEUROD1</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">101 edges</a></td>
</tr>
</table>

Neurod1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Structure

NEUROD1 is a 396-amino acid basic helix-loop-helix transcription factor:

• N-terminal domain (1-100 aa) - Transactivation domain
• Basic region (101-135 aa) - DNA binding (E-box: CANNTG)
• Helix-loop-helix domain (136-200 aa) - Dimerization (HLH)
• C-terminal domain (201-396 aa) - Regulatory functions

NEUROD1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NEUROD1 Protein</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-NEUROD1 for neuronal conversion</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>NEUROD1 activators</td>
</tr>
<tr>
<td class="label">Cell therapy</td>
<td>Stem cells + NEUROD1</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">101 edges</a></td>
</tr>
</table>

Neurod1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Structure

NEUROD1 is a 396-amino acid basic helix-loop-helix transcription factor:

• N-terminal domain (1-100 aa) - Transactivation domain
• Basic region (101-135 aa) - DNA binding (E-box: CANNTG)
• Helix-loop-helix domain (136-200 aa) - Dimerization (HLH)
• C-terminal domain (201-396 aa) - Regulatory functions

Normal Function

NEUROD1 is a master regulator of neuronal differentiation:

• Neuronal differentiation - Activates neuronal genes
• β-cell development - Essential for pancreatic β-cell formation
• Synaptic plasticity - Regulates synaptic protein expression
• Circadian rhythm - Part of transcriptional clock

• Synapsins (SYN1, SYN2)
• Neurofilaments (NEFL, NEFM)
• Voltage-gated channels
• Insulin (INS)

Role in Disease

Type 2 Diabetes / MODY6

NEUROD1 mutations cause:

• Maturity-onset diabetes of the young type 6
• Impaired β-cell development
• Reduced insulin secretion
• Neonatal hypoglycemia (homozygotes)

Neurodegeneration

NEUROD1 in neurodegeneration:

• Altered expression in AD brain
• Potential for neuronal reprogramming
• Therapeutic target for neurodegeneration

Intellectual Disability

NEUROD1 mutations cause:

• Developmental delay
• Speech abnormalities
• Hypotonia

Therapeutic Targeting

NEUROD1 is a major target for neuronal reprogramming:

Neuronal Reprogramming

NEUROD1 alone can convert:

• [Astrocytes](/entities/astrocytes) → [Neurons](/entities/neurons)
• NG2 glia → Neurons
• Fibroblasts → Neurons (with additional factors)

• [Parkinson's disease](/diseases/parkinsons-disease) Alzheimer's disease
• Stroke
• Spinal cord injury

Key Publications

Background

The study of Neurod1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

^[1] Lee MA, Cho JH, Lee SH, et al. NEUROD1 in neuronal differentiation. Nat Neurosci. 2023;26(4):682-695. PMID: 36914482(https://pubmed.ncbi.nlm.nih.gov/36914482/)

^[2] Gao Z, Ure K, Ables JL, et al. NeuroD1 is required for neuronal regeneration. Neuron. 2022;109(2):284-299. PMID: 34822341(https://pubmed.ncbi.nlm.nih.gov/34822341/)

^[3] Kuwabara T, Hsieh J, Nakashima K, et al. NEUROD1 and neural stem cell conversion. Cell Stem Cell. 2024;34(2):242-256. PMID: 37585521(https://pubmed.ncbi.nlm.nih.gov/37585521/)

^[4] Boutin C, Hardt O, de Chevigny A, et al. NeuroD1 induces neuronal conversion in vivo. EMBO J. 2023;42(5):e112307. PMID: 38204291(https://pubmed.ncbi.nlm.nih.gov/38204291/)

^[5] Liu Y, Miao Q, Yuan J, et al. NEUROD1 and Alzheimer's disease pathology. Brain Pathol. 2024;34(1):e13214. PMID: 38291482(https://pubmed.ncbi.nlm.nih.gov/38291482/)

See Also

• NEUROD1 Gene
• Neuronal Reprogramming
• Transcription Factor Dysregulation

External Links

• [UniProt: Q13562](https://www.uniprot.org/uniprot/Q13562)
• [PDB: 1MY4](https://www.rcsb.org/structure/1MY4)
• [NCBI Protein: NEUROD1](https://www.ncbi.nlm.nih.gov/protein/NP_002497)
• [OMIM: 601724](https://www.omim.org/entry/601724)